The Scientist

» drug monitoring

Most Recent

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: FDA Ups Recent Recalls

FDA Ups Recent Recalls

By | November 9, 2011

The US regulatory agency recalled 54 percent more drugs from the second to third quarters of 2011.

3 Comments

image: Detecting New Synthetic Drugs

Detecting New Synthetic Drugs

By | September 1, 2011

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.

0 Comments

image: Opinion: Sustainable Drug Monitoring

Opinion: Sustainable Drug Monitoring

By | August 31, 2011

Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham